stockmarketproxy
/
BIIBNasdaq SEC EDGAR

BIOGEN INC.

Biological Products, (No Diagnostic Substances)·CAMBRIDGE, MA·FY end 12/31·CIK 875045
OverviewFinancialsCompensationGovernanceInsidersFilings

Board of Directors

10 members · 9 independent · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
Maria C. FreireDirector5y71CompNCG$457,447
William A. HawkinsDirector7y72AuditNCG$462,447
Susan K. LangerDirector3y35Comp$439,947
Jesus B. MantasDirector7y57Comp$459,947
Lloyd MinorDirector2y68Audit$439,947
Menelas PangalosDirector1y59Comp$439,947
Monish PatolawalaDirector2y56Audit$447,447
Eric K. RowinskyDirector16y69CompNCG$454,947
Stephen A. SherwinDirector16y77Audit$439,947
Christopher A. ViehbacherCEO and Director4y66

Risk-factor diff

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.